1 / 4

Supplementary Figure S1

Supplementary Figure S1 Change of reporter activity levels after actinomycin D treatment. HEK293T cells were transiently transfected with the reporter and incubated with actinomycin D for the indicated times.

haled
Download Presentation

Supplementary Figure S1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Supplementary Figure S1 • Change of reporter activity levels after actinomycin D treatment. HEK293T cells were transiently transfected with the reporter and incubated with actinomycin D for the indicated times. • Schematic presentation of deletion constructs of mcry1 3’UTR and their reporter activity. • Change of reporter mRNA levels after actinomycin D treatment. NIH3T3 cells were transiently transfected with the reporter and incubated with actinomycin D for the indicated times. • Each 3′UTR in vitro transcribed with 32- αP-rUTP was subjected to in vitro binding and UV cross-linking assay with HEK 293T nuclear extract. The arrow indicates the proteins that shows differential binding. • wt 3′UTR in vitro transcribed with 32- αP-rUTP was subjected to in vitro binding and UV cross-linking assay with HEK 293T cytoplasmic extract and unlabeled cold wtUTR. The arrow indicates the proteins that shows differential binding. • Each 3′UTR in vitro transcribed with 32- αP-rUTP was subjected to in vitro binding and UV cross-linking assay with NIH-3T3 cytoplasmic extract. The arrow indicates the proteins that shows differential binding. • wt 3′UTR in vitro transcribed with 32- αP-rUTP was subjected to in vitro binding and UV cross-linking assay with HEK 293T cytoplasmic extract and homo-oligoribonucleotide A, C, and U. The arrow indicates the proteins that shows differential binding. • Alignment of conserved U-tract sequences among various species compared with between 252 and 280 in mcry1 3'UTR.

  2. NAT activity 0 20 40 60 80 100 120 CMV NAT pcNAT mcry1_3′UTR 1 pcNAT_wt610 140 201 120 401 100 pcNAT 80 AANAT activity (%of Act.D 0h) 610 pcNAT_wt610 60 1.2 pcNAT_N201 40 1.0 20 pcNAT_N401 0.8 0 Act.D 5h Act.D 0h Relative mRNA level (aanat/rpl32) 0.6 0.4 pcNAT-N401 0.2 pcNAT-N201 0.0 0 2 4 6 Time after Act.D [h] Woo et al_ Supplementary Fig. S1 A B C

  3. mCry1_3′UTR HEK_cyto + + + + homopolymer A C U 115 115 90.5 61.5 90.5 + + + HEK_nuc 61.5 wt610 + N201 + 46.2 46.2 + N401 37.5 115 37.8 90.5 + + + + + + NIH_cyto HEK_cyto 61.5 wt610 wt610 + + + + N201 + + Cold N401 46.2 115 37.5 90.5 61.5 46.2 37.5 Woo et al_ Supplementary Fig. S1 D E G F H

  4. Supplementary Table primer sequences for real time PCR

More Related